Global Self-administered Parenteral Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Self-administered Parenteral market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Self-administered Parenteral industry chain, the market status of Pharmacy (Pre-filled Syringes, Autoinjectors), Online Sales (Pre-filled Syringes, Autoinjectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Self-administered Parenteral.
Regionally, the report analyzes the Self-administered Parenteral markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Self-administered Parenteral market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Self-administered Parenteral market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Self-administered Parenteral industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Pre-filled Syringes, Autoinjectors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Self-administered Parenteral market.
Regional Analysis: The report involves examining the Self-administered Parenteral market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Self-administered Parenteral market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Self-administered Parenteral:
Company Analysis: Report covers individual Self-administered Parenteral manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Self-administered Parenteral This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmacy, Online Sales).
Technology Analysis: Report covers specific technologies relevant to Self-administered Parenteral. It assesses the current state, advancements, and potential future developments in Self-administered Parenteral areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Self-administered Parenteral market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Self-administered Parenteral market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Self-administered Parenteral product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Self-administered Parenteral, with price, sales, revenue and global market share of Self-administered Parenteral from 2019 to 2024.
Chapter 3, the Self-administered Parenteral competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Self-administered Parenteral breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Self-administered Parenteral market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Self-administered Parenteral.
Chapter 14 and 15, to describe Self-administered Parenteral sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Self-administered Parenteral industry chain, the market status of Pharmacy (Pre-filled Syringes, Autoinjectors), Online Sales (Pre-filled Syringes, Autoinjectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Self-administered Parenteral.
Regionally, the report analyzes the Self-administered Parenteral markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Self-administered Parenteral market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Self-administered Parenteral market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Self-administered Parenteral industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Pre-filled Syringes, Autoinjectors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Self-administered Parenteral market.
Regional Analysis: The report involves examining the Self-administered Parenteral market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Self-administered Parenteral market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Self-administered Parenteral:
Company Analysis: Report covers individual Self-administered Parenteral manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Self-administered Parenteral This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmacy, Online Sales).
Technology Analysis: Report covers specific technologies relevant to Self-administered Parenteral. It assesses the current state, advancements, and potential future developments in Self-administered Parenteral areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Self-administered Parenteral market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Self-administered Parenteral market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Pre-filled Syringes
- Autoinjectors
- Pen Injectors
- Others
- Pharmacy
- Online Sales
- Other
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Hofliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
- Solteam Group
- AstraZeneca
- Enable lnjections
- CCBio
- Phillips-Medisize Corporation
- Sorrel Medical
- Krontec Healthcare
- Subcuject Aps
- Ascendia Pharmaceuticals
- West Pharmaceutical Services, Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Self-administered Parenteral product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Self-administered Parenteral, with price, sales, revenue and global market share of Self-administered Parenteral from 2019 to 2024.
Chapter 3, the Self-administered Parenteral competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Self-administered Parenteral breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Self-administered Parenteral market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Self-administered Parenteral.
Chapter 14 and 15, to describe Self-administered Parenteral sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Self-administered Parenteral
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Self-administered Parenteral Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pre-filled Syringes
1.3.3 Autoinjectors
1.3.4 Pen Injectors
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Self-administered Parenteral Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmacy
1.4.3 Online Sales
1.4.4 Other
1.5 Global Self-administered Parenteral Market Size & Forecast
1.5.1 Global Self-administered Parenteral Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Self-administered Parenteral Sales Quantity (2019-2030)
1.5.3 Global Self-administered Parenteral Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Becton, Dickinson and Company
2.1.1 Becton, Dickinson and Company Details
2.1.2 Becton, Dickinson and Company Major Business
2.1.3 Becton, Dickinson and Company Self-administered Parenteral Product and Services
2.1.4 Becton, Dickinson and Company Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Becton, Dickinson and Company Recent Developments/Updates
2.2 scPharmaceuticals
2.2.1 scPharmaceuticals Details
2.2.2 scPharmaceuticals Major Business
2.2.3 scPharmaceuticals Self-administered Parenteral Product and Services
2.2.4 scPharmaceuticals Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 scPharmaceuticals Recent Developments/Updates
2.3 Harro Hofliger
2.3.1 Harro Hofliger Details
2.3.2 Harro Hofliger Major Business
2.3.3 Harro Hofliger Self-administered Parenteral Product and Services
2.3.4 Harro Hofliger Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Harro Hofliger Recent Developments/Updates
2.4 Owen Mumford
2.4.1 Owen Mumford Details
2.4.2 Owen Mumford Major Business
2.4.3 Owen Mumford Self-administered Parenteral Product and Services
2.4.4 Owen Mumford Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Owen Mumford Recent Developments/Updates
2.5 Haselmeier
2.5.1 Haselmeier Details
2.5.2 Haselmeier Major Business
2.5.3 Haselmeier Self-administered Parenteral Product and Services
2.5.4 Haselmeier Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Haselmeier Recent Developments/Updates
2.6 Stevanato Group
2.6.1 Stevanato Group Details
2.6.2 Stevanato Group Major Business
2.6.3 Stevanato Group Self-administered Parenteral Product and Services
2.6.4 Stevanato Group Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Stevanato Group Recent Developments/Updates
2.7 Ypsomed AG
2.7.1 Ypsomed AG Details
2.7.2 Ypsomed AG Major Business
2.7.3 Ypsomed AG Self-administered Parenteral Product and Services
2.7.4 Ypsomed AG Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Ypsomed AG Recent Developments/Updates
2.8 Solteam Group
2.8.1 Solteam Group Details
2.8.2 Solteam Group Major Business
2.8.3 Solteam Group Self-administered Parenteral Product and Services
2.8.4 Solteam Group Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Solteam Group Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Self-administered Parenteral Product and Services
2.9.4 AstraZeneca Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 Enable lnjections
2.10.1 Enable lnjections Details
2.10.2 Enable lnjections Major Business
2.10.3 Enable lnjections Self-administered Parenteral Product and Services
2.10.4 Enable lnjections Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Enable lnjections Recent Developments/Updates
2.11 CCBio
2.11.1 CCBio Details
2.11.2 CCBio Major Business
2.11.3 CCBio Self-administered Parenteral Product and Services
2.11.4 CCBio Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 CCBio Recent Developments/Updates
2.12 Phillips-Medisize Corporation
2.12.1 Phillips-Medisize Corporation Details
2.12.2 Phillips-Medisize Corporation Major Business
2.12.3 Phillips-Medisize Corporation Self-administered Parenteral Product and Services
2.12.4 Phillips-Medisize Corporation Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Phillips-Medisize Corporation Recent Developments/Updates
2.13 Sorrel Medical
2.13.1 Sorrel Medical Details
2.13.2 Sorrel Medical Major Business
2.13.3 Sorrel Medical Self-administered Parenteral Product and Services
2.13.4 Sorrel Medical Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sorrel Medical Recent Developments/Updates
2.14 Krontec Healthcare
2.14.1 Krontec Healthcare Details
2.14.2 Krontec Healthcare Major Business
2.14.3 Krontec Healthcare Self-administered Parenteral Product and Services
2.14.4 Krontec Healthcare Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Krontec Healthcare Recent Developments/Updates
2.15 Subcuject Aps
2.15.1 Subcuject Aps Details
2.15.2 Subcuject Aps Major Business
2.15.3 Subcuject Aps Self-administered Parenteral Product and Services
2.15.4 Subcuject Aps Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Subcuject Aps Recent Developments/Updates
2.16 Ascendia Pharmaceuticals
2.16.1 Ascendia Pharmaceuticals Details
2.16.2 Ascendia Pharmaceuticals Major Business
2.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
2.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Ascendia Pharmaceuticals Recent Developments/Updates
2.17 West Pharmaceutical Services, Inc.
2.17.1 West Pharmaceutical Services, Inc. Details
2.17.2 West Pharmaceutical Services, Inc. Major Business
2.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
2.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SELF-ADMINISTERED PARENTERAL BY MANUFACTURER
3.1 Global Self-administered Parenteral Sales Quantity by Manufacturer (2019-2024)
3.2 Global Self-administered Parenteral Revenue by Manufacturer (2019-2024)
3.3 Global Self-administered Parenteral Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Self-administered Parenteral by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Self-administered Parenteral Manufacturer Market Share in 2023
3.4.2 Top 6 Self-administered Parenteral Manufacturer Market Share in 2023
3.5 Self-administered Parenteral Market: Overall Company Footprint Analysis
3.5.1 Self-administered Parenteral Market: Region Footprint
3.5.2 Self-administered Parenteral Market: Company Product Type Footprint
3.5.3 Self-administered Parenteral Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Self-administered Parenteral Market Size by Region
4.1.1 Global Self-administered Parenteral Sales Quantity by Region (2019-2030)
4.1.2 Global Self-administered Parenteral Consumption Value by Region (2019-2030)
4.1.3 Global Self-administered Parenteral Average Price by Region (2019-2030)
4.2 North America Self-administered Parenteral Consumption Value (2019-2030)
4.3 Europe Self-administered Parenteral Consumption Value (2019-2030)
4.4 Asia-Pacific Self-administered Parenteral Consumption Value (2019-2030)
4.5 South America Self-administered Parenteral Consumption Value (2019-2030)
4.6 Middle East and Africa Self-administered Parenteral Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Self-administered Parenteral Sales Quantity by Type (2019-2030)
5.2 Global Self-administered Parenteral Consumption Value by Type (2019-2030)
5.3 Global Self-administered Parenteral Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Self-administered Parenteral Sales Quantity by Application (2019-2030)
6.2 Global Self-administered Parenteral Consumption Value by Application (2019-2030)
6.3 Global Self-administered Parenteral Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Self-administered Parenteral Sales Quantity by Type (2019-2030)
7.2 North America Self-administered Parenteral Sales Quantity by Application (2019-2030)
7.3 North America Self-administered Parenteral Market Size by Country
7.3.1 North America Self-administered Parenteral Sales Quantity by Country (2019-2030)
7.3.2 North America Self-administered Parenteral Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Self-administered Parenteral Sales Quantity by Type (2019-2030)
8.2 Europe Self-administered Parenteral Sales Quantity by Application (2019-2030)
8.3 Europe Self-administered Parenteral Market Size by Country
8.3.1 Europe Self-administered Parenteral Sales Quantity by Country (2019-2030)
8.3.2 Europe Self-administered Parenteral Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Self-administered Parenteral Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Self-administered Parenteral Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Self-administered Parenteral Market Size by Region
9.3.1 Asia-Pacific Self-administered Parenteral Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Self-administered Parenteral Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Self-administered Parenteral Sales Quantity by Type (2019-2030)
10.2 South America Self-administered Parenteral Sales Quantity by Application (2019-2030)
10.3 South America Self-administered Parenteral Market Size by Country
10.3.1 South America Self-administered Parenteral Sales Quantity by Country (2019-2030)
10.3.2 South America Self-administered Parenteral Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Self-administered Parenteral Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Self-administered Parenteral Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Self-administered Parenteral Market Size by Country
11.3.1 Middle East & Africa Self-administered Parenteral Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Self-administered Parenteral Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Self-administered Parenteral Market Drivers
12.2 Self-administered Parenteral Market Restraints
12.3 Self-administered Parenteral Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Self-administered Parenteral and Key Manufacturers
13.2 Manufacturing Costs Percentage of Self-administered Parenteral
13.3 Self-administered Parenteral Production Process
13.4 Self-administered Parenteral Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Self-administered Parenteral Typical Distributors
14.3 Self-administered Parenteral Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Self-administered Parenteral
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Self-administered Parenteral Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pre-filled Syringes
1.3.3 Autoinjectors
1.3.4 Pen Injectors
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Self-administered Parenteral Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmacy
1.4.3 Online Sales
1.4.4 Other
1.5 Global Self-administered Parenteral Market Size & Forecast
1.5.1 Global Self-administered Parenteral Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Self-administered Parenteral Sales Quantity (2019-2030)
1.5.3 Global Self-administered Parenteral Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Becton, Dickinson and Company
2.1.1 Becton, Dickinson and Company Details
2.1.2 Becton, Dickinson and Company Major Business
2.1.3 Becton, Dickinson and Company Self-administered Parenteral Product and Services
2.1.4 Becton, Dickinson and Company Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Becton, Dickinson and Company Recent Developments/Updates
2.2 scPharmaceuticals
2.2.1 scPharmaceuticals Details
2.2.2 scPharmaceuticals Major Business
2.2.3 scPharmaceuticals Self-administered Parenteral Product and Services
2.2.4 scPharmaceuticals Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 scPharmaceuticals Recent Developments/Updates
2.3 Harro Hofliger
2.3.1 Harro Hofliger Details
2.3.2 Harro Hofliger Major Business
2.3.3 Harro Hofliger Self-administered Parenteral Product and Services
2.3.4 Harro Hofliger Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Harro Hofliger Recent Developments/Updates
2.4 Owen Mumford
2.4.1 Owen Mumford Details
2.4.2 Owen Mumford Major Business
2.4.3 Owen Mumford Self-administered Parenteral Product and Services
2.4.4 Owen Mumford Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Owen Mumford Recent Developments/Updates
2.5 Haselmeier
2.5.1 Haselmeier Details
2.5.2 Haselmeier Major Business
2.5.3 Haselmeier Self-administered Parenteral Product and Services
2.5.4 Haselmeier Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Haselmeier Recent Developments/Updates
2.6 Stevanato Group
2.6.1 Stevanato Group Details
2.6.2 Stevanato Group Major Business
2.6.3 Stevanato Group Self-administered Parenteral Product and Services
2.6.4 Stevanato Group Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Stevanato Group Recent Developments/Updates
2.7 Ypsomed AG
2.7.1 Ypsomed AG Details
2.7.2 Ypsomed AG Major Business
2.7.3 Ypsomed AG Self-administered Parenteral Product and Services
2.7.4 Ypsomed AG Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Ypsomed AG Recent Developments/Updates
2.8 Solteam Group
2.8.1 Solteam Group Details
2.8.2 Solteam Group Major Business
2.8.3 Solteam Group Self-administered Parenteral Product and Services
2.8.4 Solteam Group Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Solteam Group Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Self-administered Parenteral Product and Services
2.9.4 AstraZeneca Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 Enable lnjections
2.10.1 Enable lnjections Details
2.10.2 Enable lnjections Major Business
2.10.3 Enable lnjections Self-administered Parenteral Product and Services
2.10.4 Enable lnjections Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Enable lnjections Recent Developments/Updates
2.11 CCBio
2.11.1 CCBio Details
2.11.2 CCBio Major Business
2.11.3 CCBio Self-administered Parenteral Product and Services
2.11.4 CCBio Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 CCBio Recent Developments/Updates
2.12 Phillips-Medisize Corporation
2.12.1 Phillips-Medisize Corporation Details
2.12.2 Phillips-Medisize Corporation Major Business
2.12.3 Phillips-Medisize Corporation Self-administered Parenteral Product and Services
2.12.4 Phillips-Medisize Corporation Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Phillips-Medisize Corporation Recent Developments/Updates
2.13 Sorrel Medical
2.13.1 Sorrel Medical Details
2.13.2 Sorrel Medical Major Business
2.13.3 Sorrel Medical Self-administered Parenteral Product and Services
2.13.4 Sorrel Medical Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sorrel Medical Recent Developments/Updates
2.14 Krontec Healthcare
2.14.1 Krontec Healthcare Details
2.14.2 Krontec Healthcare Major Business
2.14.3 Krontec Healthcare Self-administered Parenteral Product and Services
2.14.4 Krontec Healthcare Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Krontec Healthcare Recent Developments/Updates
2.15 Subcuject Aps
2.15.1 Subcuject Aps Details
2.15.2 Subcuject Aps Major Business
2.15.3 Subcuject Aps Self-administered Parenteral Product and Services
2.15.4 Subcuject Aps Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Subcuject Aps Recent Developments/Updates
2.16 Ascendia Pharmaceuticals
2.16.1 Ascendia Pharmaceuticals Details
2.16.2 Ascendia Pharmaceuticals Major Business
2.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
2.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Ascendia Pharmaceuticals Recent Developments/Updates
2.17 West Pharmaceutical Services, Inc.
2.17.1 West Pharmaceutical Services, Inc. Details
2.17.2 West Pharmaceutical Services, Inc. Major Business
2.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
2.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SELF-ADMINISTERED PARENTERAL BY MANUFACTURER
3.1 Global Self-administered Parenteral Sales Quantity by Manufacturer (2019-2024)
3.2 Global Self-administered Parenteral Revenue by Manufacturer (2019-2024)
3.3 Global Self-administered Parenteral Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Self-administered Parenteral by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Self-administered Parenteral Manufacturer Market Share in 2023
3.4.2 Top 6 Self-administered Parenteral Manufacturer Market Share in 2023
3.5 Self-administered Parenteral Market: Overall Company Footprint Analysis
3.5.1 Self-administered Parenteral Market: Region Footprint
3.5.2 Self-administered Parenteral Market: Company Product Type Footprint
3.5.3 Self-administered Parenteral Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Self-administered Parenteral Market Size by Region
4.1.1 Global Self-administered Parenteral Sales Quantity by Region (2019-2030)
4.1.2 Global Self-administered Parenteral Consumption Value by Region (2019-2030)
4.1.3 Global Self-administered Parenteral Average Price by Region (2019-2030)
4.2 North America Self-administered Parenteral Consumption Value (2019-2030)
4.3 Europe Self-administered Parenteral Consumption Value (2019-2030)
4.4 Asia-Pacific Self-administered Parenteral Consumption Value (2019-2030)
4.5 South America Self-administered Parenteral Consumption Value (2019-2030)
4.6 Middle East and Africa Self-administered Parenteral Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Self-administered Parenteral Sales Quantity by Type (2019-2030)
5.2 Global Self-administered Parenteral Consumption Value by Type (2019-2030)
5.3 Global Self-administered Parenteral Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Self-administered Parenteral Sales Quantity by Application (2019-2030)
6.2 Global Self-administered Parenteral Consumption Value by Application (2019-2030)
6.3 Global Self-administered Parenteral Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Self-administered Parenteral Sales Quantity by Type (2019-2030)
7.2 North America Self-administered Parenteral Sales Quantity by Application (2019-2030)
7.3 North America Self-administered Parenteral Market Size by Country
7.3.1 North America Self-administered Parenteral Sales Quantity by Country (2019-2030)
7.3.2 North America Self-administered Parenteral Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Self-administered Parenteral Sales Quantity by Type (2019-2030)
8.2 Europe Self-administered Parenteral Sales Quantity by Application (2019-2030)
8.3 Europe Self-administered Parenteral Market Size by Country
8.3.1 Europe Self-administered Parenteral Sales Quantity by Country (2019-2030)
8.3.2 Europe Self-administered Parenteral Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Self-administered Parenteral Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Self-administered Parenteral Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Self-administered Parenteral Market Size by Region
9.3.1 Asia-Pacific Self-administered Parenteral Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Self-administered Parenteral Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Self-administered Parenteral Sales Quantity by Type (2019-2030)
10.2 South America Self-administered Parenteral Sales Quantity by Application (2019-2030)
10.3 South America Self-administered Parenteral Market Size by Country
10.3.1 South America Self-administered Parenteral Sales Quantity by Country (2019-2030)
10.3.2 South America Self-administered Parenteral Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Self-administered Parenteral Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Self-administered Parenteral Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Self-administered Parenteral Market Size by Country
11.3.1 Middle East & Africa Self-administered Parenteral Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Self-administered Parenteral Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Self-administered Parenteral Market Drivers
12.2 Self-administered Parenteral Market Restraints
12.3 Self-administered Parenteral Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Self-administered Parenteral and Key Manufacturers
13.2 Manufacturing Costs Percentage of Self-administered Parenteral
13.3 Self-administered Parenteral Production Process
13.4 Self-administered Parenteral Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Self-administered Parenteral Typical Distributors
14.3 Self-administered Parenteral Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Self-administered Parenteral Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Self-administered Parenteral Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 4. Becton, Dickinson and Company Major Business
Table 5. Becton, Dickinson and Company Self-administered Parenteral Product and Services
Table 6. Becton, Dickinson and Company Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Becton, Dickinson and Company Recent Developments/Updates
Table 8. scPharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. scPharmaceuticals Major Business
Table 10. scPharmaceuticals Self-administered Parenteral Product and Services
Table 11. scPharmaceuticals Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. scPharmaceuticals Recent Developments/Updates
Table 13. Harro Hofliger Basic Information, Manufacturing Base and Competitors
Table 14. Harro Hofliger Major Business
Table 15. Harro Hofliger Self-administered Parenteral Product and Services
Table 16. Harro Hofliger Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Harro Hofliger Recent Developments/Updates
Table 18. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 19. Owen Mumford Major Business
Table 20. Owen Mumford Self-administered Parenteral Product and Services
Table 21. Owen Mumford Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Owen Mumford Recent Developments/Updates
Table 23. Haselmeier Basic Information, Manufacturing Base and Competitors
Table 24. Haselmeier Major Business
Table 25. Haselmeier Self-administered Parenteral Product and Services
Table 26. Haselmeier Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Haselmeier Recent Developments/Updates
Table 28. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 29. Stevanato Group Major Business
Table 30. Stevanato Group Self-administered Parenteral Product and Services
Table 31. Stevanato Group Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Stevanato Group Recent Developments/Updates
Table 33. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 34. Ypsomed AG Major Business
Table 35. Ypsomed AG Self-administered Parenteral Product and Services
Table 36. Ypsomed AG Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Ypsomed AG Recent Developments/Updates
Table 38. Solteam Group Basic Information, Manufacturing Base and Competitors
Table 39. Solteam Group Major Business
Table 40. Solteam Group Self-administered Parenteral Product and Services
Table 41. Solteam Group Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Solteam Group Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Self-administered Parenteral Product and Services
Table 46. AstraZeneca Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. Enable lnjections Basic Information, Manufacturing Base and Competitors
Table 49. Enable lnjections Major Business
Table 50. Enable lnjections Self-administered Parenteral Product and Services
Table 51. Enable lnjections Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Enable lnjections Recent Developments/Updates
Table 53. CCBio Basic Information, Manufacturing Base and Competitors
Table 54. CCBio Major Business
Table 55. CCBio Self-administered Parenteral Product and Services
Table 56. CCBio Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. CCBio Recent Developments/Updates
Table 58. Phillips-Medisize Corporation Basic Information, Manufacturing Base and Competitors
Table 59. Phillips-Medisize Corporation Major Business
Table 60. Phillips-Medisize Corporation Self-administered Parenteral Product and Services
Table 61. Phillips-Medisize Corporation Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Phillips-Medisize Corporation Recent Developments/Updates
Table 63. Sorrel Medical Basic Information, Manufacturing Base and Competitors
Table 64. Sorrel Medical Major Business
Table 65. Sorrel Medical Self-administered Parenteral Product and Services
Table 66. Sorrel Medical Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Sorrel Medical Recent Developments/Updates
Table 68. Krontec Healthcare Basic Information, Manufacturing Base and Competitors
Table 69. Krontec Healthcare Major Business
Table 70. Krontec Healthcare Self-administered Parenteral Product and Services
Table 71. Krontec Healthcare Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Krontec Healthcare Recent Developments/Updates
Table 73. Subcuject Aps Basic Information, Manufacturing Base and Competitors
Table 74. Subcuject Aps Major Business
Table 75. Subcuject Aps Self-administered Parenteral Product and Services
Table 76. Subcuject Aps Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Subcuject Aps Recent Developments/Updates
Table 78. Ascendia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Ascendia Pharmaceuticals Major Business
Table 80. Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
Table 81. Ascendia Pharmaceuticals Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Ascendia Pharmaceuticals Recent Developments/Updates
Table 83. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. West Pharmaceutical Services, Inc. Major Business
Table 85. West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
Table 86. West Pharmaceutical Services, Inc. Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 88. Global Self-administered Parenteral Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 89. Global Self-administered Parenteral Revenue by Manufacturer (2019-2024) & (USD Million)
Table 90. Global Self-administered Parenteral Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 91. Market Position of Manufacturers in Self-administered Parenteral, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 92. Head Office and Self-administered Parenteral Production Site of Key Manufacturer
Table 93. Self-administered Parenteral Market: Company Product Type Footprint
Table 94. Self-administered Parenteral Market: Company Product Application Footprint
Table 95. Self-administered Parenteral New Market Entrants and Barriers to Market Entry
Table 96. Self-administered Parenteral Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Self-administered Parenteral Sales Quantity by Region (2019-2024) & (K Units)
Table 98. Global Self-administered Parenteral Sales Quantity by Region (2025-2030) & (K Units)
Table 99. Global Self-administered Parenteral Consumption Value by Region (2019-2024) & (USD Million)
Table 100. Global Self-administered Parenteral Consumption Value by Region (2025-2030) & (USD Million)
Table 101. Global Self-administered Parenteral Average Price by Region (2019-2024) & (US$/Unit)
Table 102. Global Self-administered Parenteral Average Price by Region (2025-2030) & (US$/Unit)
Table 103. Global Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Global Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Global Self-administered Parenteral Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Global Self-administered Parenteral Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Global Self-administered Parenteral Average Price by Type (2019-2024) & (US$/Unit)
Table 108. Global Self-administered Parenteral Average Price by Type (2025-2030) & (US$/Unit)
Table 109. Global Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Global Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Global Self-administered Parenteral Consumption Value by Application (2019-2024) & (USD Million)
Table 112. Global Self-administered Parenteral Consumption Value by Application (2025-2030) & (USD Million)
Table 113. Global Self-administered Parenteral Average Price by Application (2019-2024) & (US$/Unit)
Table 114. Global Self-administered Parenteral Average Price by Application (2025-2030) & (US$/Unit)
Table 115. North America Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 116. North America Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 117. North America Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 118. North America Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 119. North America Self-administered Parenteral Sales Quantity by Country (2019-2024) & (K Units)
Table 120. North America Self-administered Parenteral Sales Quantity by Country (2025-2030) & (K Units)
Table 121. North America Self-administered Parenteral Consumption Value by Country (2019-2024) & (USD Million)
Table 122. North America Self-administered Parenteral Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Europe Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 124. Europe Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 125. Europe Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 126. Europe Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 127. Europe Self-administered Parenteral Sales Quantity by Country (2019-2024) & (K Units)
Table 128. Europe Self-administered Parenteral Sales Quantity by Country (2025-2030) & (K Units)
Table 129. Europe Self-administered Parenteral Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Self-administered Parenteral Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 132. Asia-Pacific Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 133. Asia-Pacific Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 134. Asia-Pacific Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 135. Asia-Pacific Self-administered Parenteral Sales Quantity by Region (2019-2024) & (K Units)
Table 136. Asia-Pacific Self-administered Parenteral Sales Quantity by Region (2025-2030) & (K Units)
Table 137. Asia-Pacific Self-administered Parenteral Consumption Value by Region (2019-2024) & (USD Million)
Table 138. Asia-Pacific Self-administered Parenteral Consumption Value by Region (2025-2030) & (USD Million)
Table 139. South America Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 140. South America Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 141. South America Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 142. South America Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 143. South America Self-administered Parenteral Sales Quantity by Country (2019-2024) & (K Units)
Table 144. South America Self-administered Parenteral Sales Quantity by Country (2025-2030) & (K Units)
Table 145. South America Self-administered Parenteral Consumption Value by Country (2019-2024) & (USD Million)
Table 146. South America Self-administered Parenteral Consumption Value by Country (2025-2030) & (USD Million)
Table 147. Middle East & Africa Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 148. Middle East & Africa Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 149. Middle East & Africa Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 150. Middle East & Africa Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 151. Middle East & Africa Self-administered Parenteral Sales Quantity by Region (2019-2024) & (K Units)
Table 152. Middle East & Africa Self-administered Parenteral Sales Quantity by Region (2025-2030) & (K Units)
Table 153. Middle East & Africa Self-administered Parenteral Consumption Value by Region (2019-2024) & (USD Million)
Table 154. Middle East & Africa Self-administered Parenteral Consumption Value by Region (2025-2030) & (USD Million)
Table 155. Self-administered Parenteral Raw Material
Table 156. Key Manufacturers of Self-administered Parenteral Raw Materials
Table 157. Self-administered Parenteral Typical Distributors
Table 158. Self-administered Parenteral Typical Customers
LIST OF FIGURE
s
Figure 1. Self-administered Parenteral Picture
Figure 2. Global Self-administered Parenteral Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Self-administered Parenteral Consumption Value Market Share by Type in 2023
Figure 4. Pre-filled Syringes Examples
Figure 5. Autoinjectors Examples
Figure 6. Pen Injectors Examples
Figure 7. Others Examples
Figure 8. Global Self-administered Parenteral Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Self-administered Parenteral Consumption Value Market Share by Application in 2023
Figure 10. Pharmacy Examples
Figure 11. Online Sales Examples
Figure 12. Other Examples
Figure 13. Global Self-administered Parenteral Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Self-administered Parenteral Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Self-administered Parenteral Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Self-administered Parenteral Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Self-administered Parenteral Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Self-administered Parenteral Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Self-administered Parenteral by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Self-administered Parenteral Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Self-administered Parenteral Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Self-administered Parenteral Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Self-administered Parenteral Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Self-administered Parenteral Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Self-administered Parenteral Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Self-administered Parenteral Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Self-administered Parenteral Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Self-administered Parenteral Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Self-administered Parenteral Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Self-administered Parenteral Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Self-administered Parenteral Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Self-administered Parenteral Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Self-administered Parenteral Consumption Value Market Share by Region (2019-2030)
Figure 55. China Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Self-administered Parenteral Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Self-administered Parenteral Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Self-administered Parenteral Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Self-administered Parenteral Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Self-administered Parenteral Market Drivers
Figure 76. Self-administered Parenteral Market Restraints
Figure 77. Self-administered Parenteral Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Self-administered Parenteral in 2023
Figure 80. Manufacturing Process Analysis of Self-administered Parenteral
Figure 81. Self-administered Parenteral Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Table 1. Global Self-administered Parenteral Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Self-administered Parenteral Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 4. Becton, Dickinson and Company Major Business
Table 5. Becton, Dickinson and Company Self-administered Parenteral Product and Services
Table 6. Becton, Dickinson and Company Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Becton, Dickinson and Company Recent Developments/Updates
Table 8. scPharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. scPharmaceuticals Major Business
Table 10. scPharmaceuticals Self-administered Parenteral Product and Services
Table 11. scPharmaceuticals Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. scPharmaceuticals Recent Developments/Updates
Table 13. Harro Hofliger Basic Information, Manufacturing Base and Competitors
Table 14. Harro Hofliger Major Business
Table 15. Harro Hofliger Self-administered Parenteral Product and Services
Table 16. Harro Hofliger Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Harro Hofliger Recent Developments/Updates
Table 18. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 19. Owen Mumford Major Business
Table 20. Owen Mumford Self-administered Parenteral Product and Services
Table 21. Owen Mumford Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Owen Mumford Recent Developments/Updates
Table 23. Haselmeier Basic Information, Manufacturing Base and Competitors
Table 24. Haselmeier Major Business
Table 25. Haselmeier Self-administered Parenteral Product and Services
Table 26. Haselmeier Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Haselmeier Recent Developments/Updates
Table 28. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 29. Stevanato Group Major Business
Table 30. Stevanato Group Self-administered Parenteral Product and Services
Table 31. Stevanato Group Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Stevanato Group Recent Developments/Updates
Table 33. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 34. Ypsomed AG Major Business
Table 35. Ypsomed AG Self-administered Parenteral Product and Services
Table 36. Ypsomed AG Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Ypsomed AG Recent Developments/Updates
Table 38. Solteam Group Basic Information, Manufacturing Base and Competitors
Table 39. Solteam Group Major Business
Table 40. Solteam Group Self-administered Parenteral Product and Services
Table 41. Solteam Group Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Solteam Group Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Self-administered Parenteral Product and Services
Table 46. AstraZeneca Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. Enable lnjections Basic Information, Manufacturing Base and Competitors
Table 49. Enable lnjections Major Business
Table 50. Enable lnjections Self-administered Parenteral Product and Services
Table 51. Enable lnjections Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Enable lnjections Recent Developments/Updates
Table 53. CCBio Basic Information, Manufacturing Base and Competitors
Table 54. CCBio Major Business
Table 55. CCBio Self-administered Parenteral Product and Services
Table 56. CCBio Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. CCBio Recent Developments/Updates
Table 58. Phillips-Medisize Corporation Basic Information, Manufacturing Base and Competitors
Table 59. Phillips-Medisize Corporation Major Business
Table 60. Phillips-Medisize Corporation Self-administered Parenteral Product and Services
Table 61. Phillips-Medisize Corporation Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Phillips-Medisize Corporation Recent Developments/Updates
Table 63. Sorrel Medical Basic Information, Manufacturing Base and Competitors
Table 64. Sorrel Medical Major Business
Table 65. Sorrel Medical Self-administered Parenteral Product and Services
Table 66. Sorrel Medical Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Sorrel Medical Recent Developments/Updates
Table 68. Krontec Healthcare Basic Information, Manufacturing Base and Competitors
Table 69. Krontec Healthcare Major Business
Table 70. Krontec Healthcare Self-administered Parenteral Product and Services
Table 71. Krontec Healthcare Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Krontec Healthcare Recent Developments/Updates
Table 73. Subcuject Aps Basic Information, Manufacturing Base and Competitors
Table 74. Subcuject Aps Major Business
Table 75. Subcuject Aps Self-administered Parenteral Product and Services
Table 76. Subcuject Aps Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Subcuject Aps Recent Developments/Updates
Table 78. Ascendia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Ascendia Pharmaceuticals Major Business
Table 80. Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
Table 81. Ascendia Pharmaceuticals Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Ascendia Pharmaceuticals Recent Developments/Updates
Table 83. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. West Pharmaceutical Services, Inc. Major Business
Table 85. West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
Table 86. West Pharmaceutical Services, Inc. Self-administered Parenteral Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 88. Global Self-administered Parenteral Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 89. Global Self-administered Parenteral Revenue by Manufacturer (2019-2024) & (USD Million)
Table 90. Global Self-administered Parenteral Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 91. Market Position of Manufacturers in Self-administered Parenteral, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 92. Head Office and Self-administered Parenteral Production Site of Key Manufacturer
Table 93. Self-administered Parenteral Market: Company Product Type Footprint
Table 94. Self-administered Parenteral Market: Company Product Application Footprint
Table 95. Self-administered Parenteral New Market Entrants and Barriers to Market Entry
Table 96. Self-administered Parenteral Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Self-administered Parenteral Sales Quantity by Region (2019-2024) & (K Units)
Table 98. Global Self-administered Parenteral Sales Quantity by Region (2025-2030) & (K Units)
Table 99. Global Self-administered Parenteral Consumption Value by Region (2019-2024) & (USD Million)
Table 100. Global Self-administered Parenteral Consumption Value by Region (2025-2030) & (USD Million)
Table 101. Global Self-administered Parenteral Average Price by Region (2019-2024) & (US$/Unit)
Table 102. Global Self-administered Parenteral Average Price by Region (2025-2030) & (US$/Unit)
Table 103. Global Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Global Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Global Self-administered Parenteral Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Global Self-administered Parenteral Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Global Self-administered Parenteral Average Price by Type (2019-2024) & (US$/Unit)
Table 108. Global Self-administered Parenteral Average Price by Type (2025-2030) & (US$/Unit)
Table 109. Global Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Global Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Global Self-administered Parenteral Consumption Value by Application (2019-2024) & (USD Million)
Table 112. Global Self-administered Parenteral Consumption Value by Application (2025-2030) & (USD Million)
Table 113. Global Self-administered Parenteral Average Price by Application (2019-2024) & (US$/Unit)
Table 114. Global Self-administered Parenteral Average Price by Application (2025-2030) & (US$/Unit)
Table 115. North America Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 116. North America Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 117. North America Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 118. North America Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 119. North America Self-administered Parenteral Sales Quantity by Country (2019-2024) & (K Units)
Table 120. North America Self-administered Parenteral Sales Quantity by Country (2025-2030) & (K Units)
Table 121. North America Self-administered Parenteral Consumption Value by Country (2019-2024) & (USD Million)
Table 122. North America Self-administered Parenteral Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Europe Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 124. Europe Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 125. Europe Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 126. Europe Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 127. Europe Self-administered Parenteral Sales Quantity by Country (2019-2024) & (K Units)
Table 128. Europe Self-administered Parenteral Sales Quantity by Country (2025-2030) & (K Units)
Table 129. Europe Self-administered Parenteral Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Self-administered Parenteral Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 132. Asia-Pacific Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 133. Asia-Pacific Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 134. Asia-Pacific Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 135. Asia-Pacific Self-administered Parenteral Sales Quantity by Region (2019-2024) & (K Units)
Table 136. Asia-Pacific Self-administered Parenteral Sales Quantity by Region (2025-2030) & (K Units)
Table 137. Asia-Pacific Self-administered Parenteral Consumption Value by Region (2019-2024) & (USD Million)
Table 138. Asia-Pacific Self-administered Parenteral Consumption Value by Region (2025-2030) & (USD Million)
Table 139. South America Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 140. South America Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 141. South America Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 142. South America Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 143. South America Self-administered Parenteral Sales Quantity by Country (2019-2024) & (K Units)
Table 144. South America Self-administered Parenteral Sales Quantity by Country (2025-2030) & (K Units)
Table 145. South America Self-administered Parenteral Consumption Value by Country (2019-2024) & (USD Million)
Table 146. South America Self-administered Parenteral Consumption Value by Country (2025-2030) & (USD Million)
Table 147. Middle East & Africa Self-administered Parenteral Sales Quantity by Type (2019-2024) & (K Units)
Table 148. Middle East & Africa Self-administered Parenteral Sales Quantity by Type (2025-2030) & (K Units)
Table 149. Middle East & Africa Self-administered Parenteral Sales Quantity by Application (2019-2024) & (K Units)
Table 150. Middle East & Africa Self-administered Parenteral Sales Quantity by Application (2025-2030) & (K Units)
Table 151. Middle East & Africa Self-administered Parenteral Sales Quantity by Region (2019-2024) & (K Units)
Table 152. Middle East & Africa Self-administered Parenteral Sales Quantity by Region (2025-2030) & (K Units)
Table 153. Middle East & Africa Self-administered Parenteral Consumption Value by Region (2019-2024) & (USD Million)
Table 154. Middle East & Africa Self-administered Parenteral Consumption Value by Region (2025-2030) & (USD Million)
Table 155. Self-administered Parenteral Raw Material
Table 156. Key Manufacturers of Self-administered Parenteral Raw Materials
Table 157. Self-administered Parenteral Typical Distributors
Table 158. Self-administered Parenteral Typical Customers
LIST OF FIGURE
s
Figure 1. Self-administered Parenteral Picture
Figure 2. Global Self-administered Parenteral Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Self-administered Parenteral Consumption Value Market Share by Type in 2023
Figure 4. Pre-filled Syringes Examples
Figure 5. Autoinjectors Examples
Figure 6. Pen Injectors Examples
Figure 7. Others Examples
Figure 8. Global Self-administered Parenteral Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Self-administered Parenteral Consumption Value Market Share by Application in 2023
Figure 10. Pharmacy Examples
Figure 11. Online Sales Examples
Figure 12. Other Examples
Figure 13. Global Self-administered Parenteral Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Self-administered Parenteral Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Self-administered Parenteral Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Self-administered Parenteral Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Self-administered Parenteral Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Self-administered Parenteral Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Self-administered Parenteral by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Self-administered Parenteral Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Self-administered Parenteral Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Self-administered Parenteral Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Self-administered Parenteral Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Self-administered Parenteral Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Self-administered Parenteral Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Self-administered Parenteral Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Self-administered Parenteral Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Self-administered Parenteral Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Self-administered Parenteral Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Self-administered Parenteral Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Self-administered Parenteral Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Self-administered Parenteral Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Self-administered Parenteral Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Self-administered Parenteral Consumption Value Market Share by Region (2019-2030)
Figure 55. China Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Self-administered Parenteral Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Self-administered Parenteral Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Self-administered Parenteral Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Self-administered Parenteral Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Self-administered Parenteral Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Self-administered Parenteral Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Self-administered Parenteral Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Self-administered Parenteral Market Drivers
Figure 76. Self-administered Parenteral Market Restraints
Figure 77. Self-administered Parenteral Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Self-administered Parenteral in 2023
Figure 80. Manufacturing Process Analysis of Self-administered Parenteral
Figure 81. Self-administered Parenteral Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
